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The clinical presentation and epidemiology for patients with enteric fever at two hospitals in
East London during 2007–2012 is described with the aim to identify preventive opportunities
and to reduce the cost of treatment.
Methods
A retrospective analysis of case notes from patients admitted with enteric fever during 2007
to 2012 with a microbiologically confirmed diagnosis was undertaken. Details on clinical
presentation, travel history, demographic data, laboratory parameters, treatment, patient
outcome and vaccination status were collected.
Results
Clinical case notes were available for 98/129 (76%) patients including 69 Salmonella enter-
ica serovar Typhi (S. Typhi) and 29 Salmonella enterica serovar Paratyphi (S. Paratyphi).
Thirty-four patients (35%) were discharged from emergency medicine without a diagnosis
of enteric fever and then readmitted after positive blood cultures. Seventy-one of the 98 pa-
tients (72%) were UK residents who had travelled abroad, 23 (23%) were foreign visitors/
new entrants to the UK and four (4%) had not travelled abroad. Enteric fever was not con-
sidered in the initial differential diagnosis for 48/98 (49%) cases. The median length of hos-
pital stay was 7 days (range 0–57 days). The total cost of bed days for managing enteric
fever was £454,000 in the two hospitals (mean £75,666/year). Median time to clinical reso-
lution was five days (range 1–20). Seven of 98 (7%) patients were readmitted with relapsed
or continued infection. Six of the 71 (8%) patients had received typhoid vaccination, 34
(48%) patients had not received vaccination, and for 31 cases (44%) vaccination status
was unknown.
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Conclusions
Further interventions regarding education and vaccination of travellers and recognition of
the condition by emergency medicine clinicians in travellers to South Asia is required.
Introduction
Enteric fever, often described in the literature as typhoid fever, is characterised by a non-specif-
ic illness with low grade fever, malaise, dry cough, and abdominal pain. The infection is caused
by Salmonella enterica serovar Typhi (S. Typhi), and Salmonella enteric serovar Paratyphi (S.
Paratyphi) A, B, or C and is acquired by ingestion of contaminated food and water [1]. Early
recognition and public health interventions for enteric fever are important for high risk cases
such as those working within the food industry or attending nursery to prevent
onward transmission.
It is estimated that globally there are 27 million cases of enteric fever occurring each year [2]
with estimates of mortality varying from 216,000 to 600,000 per annum [3, 4]. The majority of
cases of enteric fever are reported in South Asia [3]. A recent population based surveillance
study indicated a high incidence of enteric fever in India and Pakistan, intermediate incidence
in Indonesia, and low incidence in China and Vietnam [5]. Outbreaks of enteric fever in sub-
Saharan Africa are increasingly being described, and the incidence appears to be on the decline
in Latin America [2, 3, 6].
Lack of access to safe food and water, poor sanitation and a limited public health infrastruc-
ture to support health education and vaccination programmes contribute to the on-going risk
of enteric fever in both residents of and travellers to endemic countries.
In 2012, 354 laboratory confirmed cases of enteric fever were reported in England, Wales
and Northern Ireland (EWNI) by Public Health England of which 303 (86%) were travel relat-
ed [7]. S. Typhi accounted for 50% of cases and 50% were S. Paratyphi. Of the total, 303 cases
were UK residents who had travelled abroad, the majority were of Indian, Pakistani or Bangla-
deshi ethnicity who had travelled to South Asia to visit friends and relatives; these findings
were consistent with previous years [7].
London accounts for around 40% of cases reported in EWNI [7, 8], with North and East
London (particularly the East London Boroughs of Newham and Tower Hamlets) reporting
the highest incidence rates [8]. This is most likely due to the high proportion of Indian, Paki-
stani and Bangladeshi ethnic groups residing in these areas [9]. Those of Bangladeshi ethnicity
(most from Sylhet) [10] are particularly concentrated in Tower Hamlets (representing 32% of
this population in 2011) [9]. The epidemiology and antibiotic resistance of enteric fever in East
London during the period 2005–2010 has been described in an earlier study [8], where the
costs to the NHS associated with treating these infections in East London were estimated to be
£272,747 over the six years. Following this study, local public health intervention to improve
vaccine uptake was undertaken.
The aim of this study was 1) to describe in detail the clinical features, laboratory markers,
epidemiology and management of patients with enteric fever presenting at the Royal London
Hospital and Newham General Hospital (now part of Barts Health NHS Trust) in East London
between 2007 and 2012 and 2) to identify preventive opportunities, and thereby reducing the
cost of treating enteric fever in East London.
East London Experience with Enteric Fever 2007-2012
PLOS ONE | DOI:10.1371/journal.pone.0120926 March 19, 2015 2 / 15
Methods
Inclusion criteria
All patients seen in the emergency medicine department at Newham General Hospital and the
Royal London Hospital with blood cultures positive for S. Typhi or S. Paratyphi during the pe-
riod 1 January 2007 to 31 December 2012 inclusive were included in this study.
Data collection and microbiology methods
Microbiological records were reviewed for patients admitted with enteric fever at the Royal
London and Newham General hospitals over the study period. This study was designed as a
non-interventional, retrospective analysis of case notes from patients admitted with enteric
fever at two London hospitals. The clinical case notes of 98/129 (76%) patients admitted during
January 2007 to December 2012 with a microbiologically confirmed diagnosis of enteric fever
were available for review. We actively searched the case notes for details on clinical presenta-
tion, travel history, demographic data, laboratory parameters, treatment and patient outcome
including relapse and eradication. S. Typhi and S. Paratyphi systemic infection was defined by
at least one positive blood culture. The organisms were cultured on selective media and identi-
fied by API 20E (BioMerieux) or MALDI-TOF MS (Bruker Corporation) and serology. Data
from Public Health England enteric fever enhanced surveillance [1, 11] were used to determine
the vaccination status and travel history in each case. Clinical correlates with isolate antibiotic
susceptibilities will be the subject of a further report.
Diagnosis and patient management
Patients with suspected enteric fever were admitted via emergency medicine and treated empir-
ically with ceftriaxone, azithromycin or ciprofloxacin; therapy was changed as necessary after
antimicrobial susceptibility results became available. Clinical advice was provided by medical
staff in the Division of Infection, at Barts Health NHS Trust.
Clinical failure was defined as either persistence or recurrence of presenting symptoms or
increase in severity of at least one sign or symptom after seven days of antibiotic treatment for
infection. Relapse was defined as recurrence of enteric fever related symptoms confirmed by
positive blood culture within one month of initial presentation. Fever clearance time was de-
fined as time from onset of treatment to first recorded temperature of37.5C which persisted
for 48 hours or more. Severe infection was defined as multi-organ involvement with sepsis and-
/or admission to an intensive care unit. Length of hospital stay was defined as the time in days
from hospital admission until discharge. Convalescent faecal carriage was defined as a positive
faecal culture detected at any time after the end of treatment up to one year following the date
of diagnosis. Abnormal biochemistry and haematology results were defined as any values
which occurred outside the normal range for the testing laboratory. Biochemistry data collected
included alkaline phosphatase (ALP), alanine transaminase (ALT), bilirubin, and C-reactive
protein (CRP) values. Haematology data included white cell count (WCC), neutrophils, lym-
phocytes, haemoglobin, and platelets for each patient.
Data analysis
An Excel database was created to manage patient information. Patient details were anonymised
and indexed using a study reference number and age in years. Comparisons between S. Typhi
and S. Paratyphi were undertaken using the Kruskal-Wallis test (for continuous data such as
length of stay) or Fisher’s exact test (for proportions). A 5% significance level was used.
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During 2007 to 2012, 111 blood cultures positive for S. Typhi were identified from 89 patients
and 48 blood cultures positive for S. Paratyphi were identified from 38 patients.
Clinical diagnosis
Of the 129 patients with microbiologically-confirmed enteric fever during the study period,
clinical case notes were available for 98/129 (76%) patients; including 69 patients with S. Typhi
infection and 29 patients with S. Paratyphi infection. All blood cultures became positive within
48 hours of sampling following admission of patients. Thirty-four patients (35%) were initially
discharged from emergency medicine without a clinical diagnosis of enteric fever and only sub-
sequently readmitted when blood cultures became positive. Stool cultures were available for 43
of the 98 patients during hospital stay and 19 of these were positive (15 S. Typhi and four S.
Paratyphi).
Demographics
Of the 98 patients reviewed, 18 (18%) were aged 17 years and under of which seven (39%) were
under five years; 28 (29%) were aged 15–24 years and 44 (45%) were aged 25–39 years
(Table 1). The median age was 25.5 years [range 0.5–68 years]. Infection was more common in
males (51/98, 52%) compared to females (47/98, 48%) but this was not statistically significant.
Forty one patients (42%) were Bangladeshi, 31(32%) were Indian and 18 (18%) were Pakistani.
Travel history
Of the total, 71/98 (72%) patients were UK residents who had travelled abroad, 23 (23%) were
foreign visitors or new entrants to the UK and four (4%) had not travelled abroad. Of UK resi-
dents who had travelled abroad, 58 (82%) had visited friends and relatives; 29 (50%) had visited
them in Bangladesh, 20 (34%) in India, and 12 (21%) in Pakistan. Two patients had visited
both Bangladesh and India and one visited both India and Pakistan. The remaining 13 patients
travelled for a holiday to other countries (Table 1). Where duration of travel information was
available (N = 62), the median duration of travel was 31 days [range 3–343 days].
Clinical features
The predominant presenting symptoms are described in Table 2. Although blood cultures were
taken in the context of fever in returning travellers, enteric fever was not initially documented
as part of the differential diagnosis in 48 (49%) of the 98 cases. Clinical symptoms, excluding
pyrexia prior to admission, were documented in 95 patients with a median of 5 days [range
1–49 days] between onset and admission.
Around half of patients presented with abdominal pain (47%, 45/95), vomiting (48%,
46/95) diarrhoea (51%, 48/95), or headache (52%, 49/95). Fever was reported in 31/95 (33%)
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and cough in 34/95 (36%). Malaise, fatigue or lethargy were reported in 10/95 (11%) of the pa-
tients. Five patients presented with constipation and four patients had hepato-splenomegaly.
Eight percent (7/89) of patients were found to be apyrexial on admission but blood cultures
were subsequently positive for enteric fever.





< 5 years old 7 7.1
0–14 15 15.3











Other ethnicity 2 2
Travel abroad/ 71 72.4
Country visited
Bangladesh 28 39.4
Bangladesh / Dubai 1 1.4
Bangladesh / India 2 2.8
Ghana 1 1.4
India 18 25.4
India / USA 1 1.4
India / Thailand 2 2.8
India / Kuwait 1 1.4





Visitor to the UK / new entrants 23 23.5
No history of foreign travel 4 4.1
Vaccination <3 years prior to travel*
Yes 6 8.5
No 34 47.9
Not Known 31 43.7
* Excludes new entrants & visitors
doi:10.1371/journal.pone.0120926.t001
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There were seven patients with severe symptoms; two with S. Paratyphi and five with S.
Typhi. One pregnant patient developed necrosis of the gall bladder and peritonitis and was ad-
mitted to the intensive care unit. One patient had perforation of the small intestine and two pa-
tients presented with neurological signs and symptoms. One patient with HIV was admitted to
intensive care with septic shock, an ex-premature baby was admitted to special care baby unit
and one patient developed sepsis with disseminated intravascular coagulation. Four patients,
with fever, abdominal pain and non-specific symptoms had already received treatment follow-
ing a diagnosis of enteric fever in South Asia. There were no recorded deaths.
For the 93 patients where data was available, the median time prior to hospital admission
from date of entry or return to the UK was 15 days [range 1–74] (Table 3). There was no rela-
tionship between age and length of time prior to presentation following entry to UK (correla-
tion r = 0.12, p = 0.25). This time period also did not differ between S. Typhi and S. Paratyphi
(p = 0.45, Table 3).
The time to admission between UK residents and visitors was not significantly different
(p = 0.388, adjusted for ties). The UK residents’median time to admission was 16 days and the
visitors’median time to admission was 13 days.
Table 2. Clinical symptoms and signs on admission for 95 patients.




Abdominal pain 45 (47)
Cough 34 (36)
Fever 31 (33)
Loss of appetite 15 (16)
Malaise/lethargy/fatigue 10 (11)
Rigors 8 (8)




Night sweats 3 (3)
CNS involvement 2 (2)
Small intestinal perforation 1 (1)
doi:10.1371/journal.pone.0120926.t002
Table 3. Temporal findings.
Total Patients n = 98 S. Typhi n = 69 S. Paratyphi n = 29
n Median Range n Median Range n Median Range
Length of Hospital Stay (days) 98 7 0–57 69 8 0–57 29 6 0–16
Temperature resolution* (days) 80 5 0–20 53 6 1–20 27 5 0–14
Clinical resolution (days) 81 5 1–20 55 5 1–20 26 4 1–14
Duration to admission from entry to the UK (days) 93 15 1–74 65 14 1–74 28 17 5–56
* does not include 11 patients who were discharged with pyrexia
doi:10.1371/journal.pone.0120926.t003
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Length of hospital stay
The median length of hospital stay was 7 days [range 0–57 days] for the 98 patients studied.
The total number of hospital bed days allocated was 908 for the 105 patient episodes. Based on
local calculations for hospital admission costs of £500 per day, the total cost of bed days for en-
teric fever was £454,000 in the two hospitals over six years (mean £75,666/year). S. Typhi in-
fected cases had a median of two more days in hospital than S. Paratyphi [range 0–57 (S.
Typhi), 0–16 (S. Paratyphi)], although this difference was not significant (p = 0.11, Table 3).
Temperature and clinical resolution
The median time to resolution of pyrexia in 80 patients was 5 days [range 0–20] (Table 3).
Among the eleven patients who had an unresolved temperature prior to discharge, there were
four patients aged 1–14 years, three patients aged 15–24 years, three patients aged 25–39 years
and one patient aged 40–59 years. Eight of these patients were sent home on oral antibiotics,
one of whom was a foreign national who continued treatment in the Netherlands. Two chil-
dren were seen daily at the hospital and given outpatient intravenous antibiotic therapy.
One of these 11 patients with unresolved pyrexia was seen in A&E but not admitted, and
did not receive antibiotic treatment, as this patient was lost to follow-up despite several at-
tempts by the emergency medicine staff to contact the patient. For the remaining 10 patients:
seven received ceftriaxone (including one in combination with gentamicin and clarithromy-
cin), one received co-amoxiclav, one received cephalexin, and one received ciprofloxacin dur-
ing their hospital stay. The range of hospital stay for these 11 patients was 0–14 days (Table 3).
The reasons for early discharge were not documented.
For the 81 patients where data was available, median time to clinical resolution following
the start of treatment was five days [range 1–20] (Table 3). Clinical resolution was significantly
longer in patients with S. Typhi (p = 0.04) compared to those infected with S. Paratyphi. Simi-
larly, temperature resolution was prolonged in patients with S. Typhi (p = 0.01) compared to
those with S. Paratyphi.
Twenty-one patients (21%) had clinical failure based on the study definition. The median
clinical resolution for these patients was 10 days [range 8–20 days]. Of these patients, two had
concurrent cryptosporidium infection and three had severe, complicated enteric fevers: one
pregnant patient was septic with peritonitis following gall bladder necrosis; one had intestinal
perforation and one patient had severe sepsis with disseminated intravascular coagulation. The
remaining 16 patients with clinical failure had a median clinical resolution of 10 days [range
8–16 days]. Reasons for this variation were unclear.
In three of the four patients who did not receive antibiotics enteric fever was not considered
in the differential diagnosis and all four were lost to follow up despite attempts by emergency
medicine staff to contact these patients. Two of these patients were visitors to the UK and may
have returned home.
Recurrence of Infection
Seven of 98 (7%) patients who had previously received treatment for enteric fever, were read-
mitted with further positive blood cultures for S. Typhi or S. Paratyphi. Six of the seven patients
had previously received at least seven days of appropriate treatment, and one patient received a
total of five days treatment (Table 4). These seven patients were treated with ceftriaxone empir-
ically. Six of these patients had S. Typhi infection and one had S. Paratyphi. Two patients were
aged 0–14 years, one aged 15–24 years, three aged 25–39 years and one patient was over 60
years old.
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Risk factors
Occupational history was recorded in the medical notes for 31 patients (32%). Nine adult pa-
tients (29%) were considered to be at high risk of transmitting infection [1]. Of these seven
were food handlers and two worked with children. In addition, there were seven children aged
less than five years who were at high risk of transmission.
Non-travel-associated cases
Four cases were designated as non-travel-associated cases. One of these had travelled to Ban-
gladesh but returned to the UK 55 days before illness onset, therefore not meeting the travel-as-
sociated case definition [1]. This case is likely to be a secondary case transmitted from one of
two co-travelling family members who both had confirmed typhoid shortly after they returned
to the UK. For the remaining three non-travel associated cases, the source of infection was un-
clear. There were two travel-associated cases that each had co-travelling family members who
had also been infected with the same organism before their onset of illness; it is therefore possi-
ble that these could also be secondary cases but not enough information was available to
determine this.
Travel history, vaccination status and clinical features
A record of enquiry about malaria prophylaxis was documented in the medical notes for 73/98
(74%) patients, and a malaria screen was performed on 70% (69/98) of patients. However, only
2/98 (2%) patients had a documented record of enquiry about typhoid vaccination.
Table 1 shows the countries visited by patients who were UK residents (N = 71) and their ty-
phoid vaccination status in the three years before travelling abroad. Of the 71 UK residents
with enteric fever: six patients (8%) had received typhoid vaccination in the three years before
travel, 34 (48%) had not received vaccination and for 31 cases (44%), vaccination status was
Table 4. Patients readmitted with infection.
















5 S. Typhi Ceftriaxone 13 Ceftriaxone 21 Cefriaxone 19
Amikacin 13
11 S. Typhi Ceftriaxone 6 Ceftriaxone 47 Ceftriaxone 8 Ciprofloxacin
Clarithromycin 1 Clarithromycin -
23 S.
Paratyphi
Ceftriaxone 2 Azithromycin 2 Ceftriaxone 13
Azithromycin 2
28 S. Typhi Amoxicillin & Gentamicin
followed by Ceftriaxone &
Amikacin
11 27 Ceftriaxone 14 Ceftriaxone
35 S. Typhi Ceftriaxone 7 Ciprofloxacin 42 Ceftriaxone 1 Amoxicillin
Ciprofloxacin 6
Amoxicillin 3
38 S. Typhi Ceftriaxone 5 23 Ceftriaxone 2 Azithromycin
Ciprofloxacin 5
66 S. Typhi Ceftriaxone 10 54 Ceftriaxone 14 Ciprofloxacin
Amoxicillin 7 Metronidazole 14
doi:10.1371/journal.pone.0120926.t004
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unknown. Five patients who had received typhoid vaccination were infected with S. Typhi and
one was infected with S. Paratyphi. The age range of these patients was 3 years to 39 years (3, 6,
18, 28, 31, 39). There was no significant difference in time to clinical resolution, resolution of
pyrexia or length of hospital stay for the patients who had received the typhoid vaccination
compared with those who did not receive vaccination. Seven patients with recurrence of infec-
tion had either not received typhoid vaccination or this information was not disclosed.
Biochemistry
Table 5 provides normal biochemistry ranges. Table 6 shows the biochemistry and haematol-
ogy findings in patients admitted with enteric fever, while Table 7 indicates the percentage of
values outside the laboratory defined normal range measured in the peripheral blood of pa-
tients taken on admission and during hospital stay with microbiological proven enteric fever.
Individual parameters were available for 73% to 98% of the 98 patients (Table 7). During
Table 5. Normal biochemistry ranges.
WCC (x109/L) Haemaglobin (g/dL) Neutrophils (x109/L) Platelets (x109/L) Lymphocytes (x109/L)
<1 6.0–16.6 11.1–14.1 1.0–7.0 200–550 3.5–11.0
<6 5.0–15.0 11.0–14.0 1.5–8.0 200–490 6.0–9.0
<12 5.0–13.0 11.5–15.5 2.0–8.0 170–450 1.0–5.0
>12 4.0–10.0 - 2.0–7.0 150–410 1.0–3.0
>12 Male - 13.0–17.0 - - -
> 12 Female - 12.0–15.0 - - -
Alanine Aminotransferase (ALT) U/L Alkaline Phosphatase (ALP) U/L Bilirubin μmol/L C-Reactive Protein (CRP) U/ml
Adult Male 10–40 30–130 < 21 < 5
Adult Female 7–35 30–130 < 21 < 5
0–12 months 13–45 55–310 < 21 < 5
> 12 months 10–40 - < 21 < 5
1 year—10 years - 55–350 < 21 < 5
Adolescent - < 520 < 21 < 5
doi:10.1371/journal.pone.0120926.t005
Table 6. Biochemistry findings in patients on admission with enteric fever.
Total patients n = 98 S. Typhi Patients n = 69 S. Paratyphi Patients n = 29
N Median Range n Median Range n Median Range
ALP 69 165 44–831 49 169 44–831 20 153.5 53–390
ALT 63 53 19–256 45 51 19–256 18 64.5 24–226
Bilirubin 59 11 2–72 41 12 3–72 18 9 2–33
WCC 90 6.3 1.3–16.1 62 6.35 1.3–16.1 28 6.3 2.7–10.6
Neutrophils 84 4.2 1.1–14.2 59 4.2 1.1–14.2 25 3.8 1.4–7.2
Lymphocytes 85 1.4 0.2–7.0 58 1.4 0.2–7.0 27 1.5 0.6–3.3
Haemoglobin
Male 43 14.1 5.5–16.0 33 13.9 9.9–15.3 10 14.5 5.5–16.0
Female 42 11.35 8.5–14.9 27 11.2 8.8–14.6 15 11.9 8.5–14.9
CRP 63 89 14–297 42 107.5 14–297 21 69 18–140
Platelets 86 180 38–339 59 167 38–339 27 208 46–333
doi:10.1371/journal.pone.0120926.t006
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hospital stay, C-reactive protein (CRP) was elevated (5 U/ml) in 87/87 (100%) of patients.
Up to 85% of patients had deranged results, during hospital stay, for other parameters: low hae-
moglobin (60/93, 65%); lymphopaenia (32/92, 35%); thrombocytopaenia (39/93, 42%); raised
ALT (66/78, 85%) and elevated ALP (56/81, 69%). Leukocytosis was present in 10/96 (10%) of
patients while leukopaenia was observed in 16/96 (17%) of patients.
During hospital stay, where data was available (N = 78) ALT was twice or greater than the
upper limit of normal in 52 patients (67%). For ALP this was the case for 28% of patients
(23/81) and for bilirubin, 8% (6/72).
The percentage of patients with abnormal white blood cell count and neutrophil count was
similar at admission for S. Typhi and S. Paratyphi infections; 13% and 11% respectively
(WCC); 12% and 12% respectively (neutrophils), but more patients with S. Typhi infection had
lymphopaenia (33% vs 19%). There was also a difference in the percentage of patients with
thrombocytopaenia on admission (39% S. Typhi vs 19% S. Paratyphi, p = 0.08).
The most pronounced differences between the two species were observed in lymphopaenia
during hospital stay (41% vs 21%, p = 0.097), thrombocytopaenia (49% vs 25%, p = 0.039), and
bilirubin (26% vs 5%, p = 0.053). Neutrophils (p = 0.029), platelets (p = 0.025) and bilirubin
(p = 0.053) abnormalities were significantly greater in S. Typhi compared to S. Paratyphi.
Discussion
This study comprised a retrospective review of enteric fever cases admitted to two hospitals in
East London over a seven year period.
The majority of patients reviewed in this study had acquired enteric fever while travelling to
visit friends and relatives in India, Pakistan and Bangladesh, with the highest proportion asso-
ciated with travel to Bangladesh. The East London Borough of Tower Hamlets has a large Ban-
gladeshi resident population, who regularly visit their families in Bangladesh.
Our findings are similar to other published reports [11, 12], and a previous study in East
London [8], where around 90% of cases of enteric fever had travelled overseas and most were
VFR travellers. It is not possible to estimate the infection rate among overseas travellers from
East London as travel statistics are not available at Borough level; however, a report from
2006–7 estimated that the rate of enteric fever associated with visits to India, Pakistan and Ban-
gladesh in VFR travellers from England, Wales and Northern Ireland was almost seven times
higher than the rate in non-VFR travellers [13]. Around 20% of visits abroad by UK residents
(just under 12 million in 2012) are to visit friends and relatives, and of those, around 7% visit
India, Pakistan and Bangladesh [14].
Our findings show that some patients with enteric fever, when seen in a UK emergency
medicine department, may either be at risk of not receiving appropriate initial antibiotic treat-
ment (as typhoid has not been considered in the differential diagnosis) or not being followed
up for enhanced surveillance (because they cannot be contacted after the blood culture results
show they have enteric fever become available). Enteric fever, unlike malaria, seems often not
to be considered as a possible diagnosis in returning travellers as the symptoms are often non-
specific.
The morbidity and mortality for enteric fever was broadly similar in our patients to that de-
scribed in the literature [15, 16]. Patients mostly presented with fever and abdominal pain, but
non-specific symptoms and respiratory symptoms were also described. Diarrhoea was com-
monly seen in adults and five percent of patients presented with constipation. Rose spots were
not described in our patients, perhaps as they are difficult to detect in an ethnic population
with darker skin. Complications were rare in our case series and all patients survived. Interest-
ingly, up to 8% (7/89) of the patients did not have an elevated temperature recorded at
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presentation. However, these patients received appropriate treatment and this issue highlights
the necessity for taking blood cultures in patients with a history of fever and return from an en-
demic area. In emergency medicine, blood cultures were taken as part of the initial assessment
but some patients may have been sent home without relevant investigations because of the
non-specific nature of presentation of enteric fever, suggesting under-diagnosis.
Clinical and temperature resolution was documented for 82% of the patients as some pa-
tients were discharged when clinically improved, despite an elevated temperature on antibiotic
treatment. However, for both features, the median resolution was rapid at five days, which is
consistent with the literature [17]. We defined clinical failure as treatment given for more than
seven days and for the great majority of the patients clinical resolution was within seven days.
For 21% of the patients, it took more than seven days for clinical resolution (median 10 days)
and some of these patients had a severe infection or had other concurrent infections. A small
number of patients had recurrent infection despite appropriate treatment with ceftriaxone,
consistent with previous reports of up to 20% recurrence rates [15–17]. There was no signifi-
cant difference in length of hospital stay between patients with S. Typhi and S. Paratyphi as
treatment was standardised and outpatient antibiotic treatment was not available locally during
the study period. However, we did find that clinical resolution and temperature resolution
were significantly prolonged in patients with S. Typhi compared to S. Paratyphi, despite the rel-
atively small numbers studied. The severity of infection in patients was not different between
the two species. The majority of our patients had abnormal laboratory parameters with anae-
mia, raised CRP and liver transaminases, as previously described in the literature [15, 16, 18].
We found that patients with S. Typhi had significantly raised bilirubin, deranged neutrophils
and also thrombocytopaenia compared with patients with S. Paratyphi. Recent reports have
suggested that S. Paratyphi has a more severe or a similar presentation to S. Typhi [19, 20],
however our findings do not support this.
While the median duration of symptoms prior to admission was five days, the range was
wide (1–49 days), although in some cases this was difficult to ascertain accurately. The late pre-
sentation of some patients with enteric fever in emergency medicine after entry to the UK may
reflect poor knowledge of access to health care, cultural and behavioural differences or partial
treatment with antibiotics before presentation. Additionally, it is possible that individuals from
endemic areas may have developed partial immunity to infection and hence may present later
with symptoms. There was also no relationship between late presentation and the species of
salmonella (S. Typhi or S. Paratyphi) causing the infection. Documentation was poor with re-
spect to risk factors for recurrent disease such as co-morbidities. Documentation was poor
with respect to risk factors for recurrent disease such as co-morbidities.
Our findings do not fully support the suggestion of others, that there may be a reservoir of
asymptomatic individuals in London who have acquired S. Typhi or S. Paratyphi abroad and
who may be a potential source of transmission to other individuals [10]. In a recent report of
enteric fever in North London [10], 19 of 329 patients (6%) had infection acquired in the UK,
suggesting that there may be a transmission risk in the community. However in our case series,
only three individuals (3%) had no relevant exposure history and were therefore possibly ac-
quired in the UK.
There were limitations with this study, the main one being that the clinical record keeping
in the hospital case notes (including temperature charts) was found to be variable among dif-
ferent clinicians and notes were only obtained for 76% of patients with a positive blood culture,
which is reported to have a sensitivity as low as 40% [21]. Certain data fields collected through
enhanced enteric fever surveillance were better completed than others; in particular, informa-
tion on vaccine history was only available for 40/71 (56%) of patients. There is also a lack of na-
tional guidance for treatment for enteric fever, which may have affected how patients were
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treated on presentation by different clinicians. Finally, despite rigorous attempts by emergency
medicine to contact patients, 4% of the patients were lost to follow up.
A very small proportion of patients reviewed were up-to-date with typhoid vaccination be-
fore travel. This may be a reflection of the ethnic mix of the population in this study as those of
Indian, Pakistani and Bangladeshi ethnicity are less likely to be vaccinated than other ethnici-
ties, particularly if born abroad [12]. More work is required to encourage prospective travellers
to seek vaccination before travelling to India, Pakistan or Bangladesh, regardless of ethnicity.
In the UK there are currently two types of vaccine available against S. Typhi, a polysaccha-
ride vaccine and an oral, live, attenuated vaccine, for both of which periodic re-immunisation
for continued efficacy is recommended [22]; there are currently no licensed vaccines against S.
Paratyphi. Existing vaccines [23, 24] are not fully protective against S. Typhi and have no pro-
tection against S. Paratyphi and some patients developed infection despite having received vac-
cination in the previous three years. Travellers, therefore, must also be provided with
appropriate health education regarding food and water hygiene precautions prior to departure.
Public Health England provides travel advice in four south Asian languages [25]. In 2012, there
was a national shortage in the availability of Vi-polysaccharide vaccines [23]; however despite
this, there was no increase in typhoid cases reported in the UK [7].
The average current cost per day for hospital admission is 500 GBPs based on local calcula-
tions. Using a conservative estimate, enteric fever cost the NHS £454,000 in two East London
Hospitals over the six year period in this study. If this was extrapolated to 354 cases of enteric
fever annually [7] with a mean stay of nine days, the costs to the NHS for England and Wales
could be over 1.5 million GBPs annually. These calculations do not include visits to primary
care, emergency medicine, additional time off work and community costs, including public
health costs. It is estimated that the incidence of enteric fever is 4–5 times higher in North East
London [10] than in the rest of England and these local costs might be reduced by the imple-
mentation of focused health education and vaccination for the prevention of enteric fever.
A study in 1994 [26] demonstrated that giving typhoid vaccine to travellers was not cost ef-
fective as the incidence of enteric fever was low (0.02%), however, there is evidence to show
that in the 21st century, travellers visiting friends and family have an increased incidence of en-
teric fever [12] and the study in east London [8] showed it would be cost effective to vaccinate
travellers. Uptake of typhoid vaccine was poor in our population at the time of the study; we
recommend that increasing awareness of the need for typhoid vaccination for travellers should
be more focussed in parts of the UK where there is a large resident population of migrants
from India, Pakistan and Bangladesh, including second and subsequent generation migrants.
Further work is needed to ascertain an accurate picture of uptake of typhoid vaccine across the
UK. Measuring the uptake of other vaccines and prophylaxis such as for viral hepatitis, rabies
and malaria in the South Asian population may also act as indicators for poor uptake of ty-
phoid vaccine and deserves discussion. One reason for poor uptake might be that cost of vac-
cines at a travel clinic may be prohibitive, particularly for a family with children, and further
work on cultural and behavioural reasons for poor vaccine uptake would be beneficial, inform-
ing future improvement plans. In some general practices, patients have to pay prescription
costs for typhoid vaccine, while hepatitis A vaccine is free. Commercial travel clinics may
charge 50 GBPs for typhoid vaccine, which represents a considerable financial burden for a
family with a number of travellers. New fourth generation vaccines are currently in develop-
ment including conjugate vaccines using various protein carriers and may be active against ei-
ther S. Typhi and S. Paratyphi, or both [24].
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Conclusions
Enteric fever is primarily a problem among returning travellers, visitors and new entrants to
the UK from South Asia. Recognition of this condition by emergency medicine was subopti-
mal; 49% of the cases did not have enteric fever documented within the initial differential diag-
nosis and 35% of patients with enteric fever were sent home from A&E and only admitted to
hospital once blood cultures became positive. There was no difference in the severity of infec-
tion caused by the two species. However, S. Typhi patients had significantly higher bilirubin
levels, deranged neutrophils, and thrombocytopaenia. Clinical relapse after a full course of
treatment requiring readmission was not uncommon. Preventative measures could be im-
proved and may be cost effective in parts of the UK where there is large resident population
from South Asia. Only 8% of the UK residents with enteric fever in our study had definitely re-
ceived vaccination in the previous three years, 48% of patients had not received vaccination
and for 44% of cases vaccination status was unknown. We found a higher percentage of enteric
fever due to S. Typhi than elsewhere, possibly because of the high proportion of Bangladeshis
in the community or low local vaccination rates.
The results of this study indicate that further action is required regarding education and
vaccination of travellers to South Asia, and the need for clinicians in emergency medicine to
consider diagnostic testing for enteric fever in travellers returning from typhoid endemic areas
with a history of fever.
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